Jurgen Durner

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Supporting trend detection in the cumulative display of electronic laboratory reports from multiple laboratories while preserving measurement provenance.

Supporting trend detection in the cumulative display of electronic laboratory reports from multiple laboratories while preserving measurement provenance.

Journal: Clinical chemistry and laboratory medicine

Published: September 03, 2025

A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease-Results from Six Years of Genetic Newborn Screening.

A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease-Results from Six Years of Genetic Newborn Screening.

Journal: Genes

Published: October 07, 2024

Time as a significant factor in the release of potassium from lithium heparin plasma and serum.

Time as a significant factor in the release of potassium from lithium heparin plasma and serum.

Journal: PloS one

Published: July 16, 2024

Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy.

Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy.

Journal: PloS one

Published: March 19, 2024

Newborn screening for aromatic l-amino acid decarboxylase deficiency - Strategies, results, and implication for prevalence calculations.

Newborn screening for aromatic l-amino acid decarboxylase deficiency - Strategies, results, and implication for prevalence calculations.

Journal: Molecular genetics and metabolism

Published: December 16, 2023

High Throughput Newborn Screening for Sickle Cell Disease - Application of Two-Tiered Testing with a qPCR-Based Primary screen.

High Throughput Newborn Screening for Sickle Cell Disease - Application of Two-Tiered Testing with a qPCR-Based Primary screen.

Journal: Klinische Padiatrie

Published: September 25, 2023

Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5.

Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5.

Journal: Medical microbiology and immunology

Published: March 16, 2023

Cell-Free DNA in Plasma and Serum Indicates Disease Severity and Prognosis in Blunt Trauma Patients.

Cell-Free DNA in Plasma and Serum Indicates Disease Severity and Prognosis in Blunt Trauma Patients.

Journal: Diagnostics (Basel, Switzerland)

Published: February 13, 2023

Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany.

Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany.

Journal: Journal of neuromuscular diseases

Published: December 04, 2022

Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages.

Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages.

Journal: Medical microbiology and immunology

Published: November 22, 2022

Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.

Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.

Journal: Medical microbiology and immunology

Published: October 14, 2022

Letter to Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome.

Letter to Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome.

Journal: EBioMedicine

Published: June 15, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026